Companies: 10,795·Total market cap: $144.5T
Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc.

UPCNASDAQHealthcare● Active
$3.62
+$0.35(+10.79%)
Market Cap$2040917
P/E Ratio
52W High$11
52W Low$2
Overview

Universe Pharmaceuticals Inc. (UPC) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · UPC · as of Jun 9, 2026

Key Statistics

EPS (TTM)upc eps ttm · upc earnings per shareEarnings history
PE Ratio (TTM)upc pe ratio ttm · upc price to earningsPE Ratio deep dive
Revenue (TTM)upc revenue ttm · upc annual revenueFull revenue history
Dividend YieldNo Dividenddoes upc pay dividends · upc dividend yieldDividend history
Shares Outstandingupc shares outstanding · upc floatShares outstanding history
Next EarningsTBAupc earnings date · upc next earningsEarnings history

About Universe Pharmaceuticals Inc.

CEOGang Lai
IPO DateMar 23, 2021
Employees225
CountryCN

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived …

what is universe pharmaceuticals inc. · upc stock overview · universe pharmaceuticals inc. company profile · who is universe pharmaceuticals inc. ceo · upc NASDAQ · universe pharmaceuticals inc. headquarters · universe pharmaceuticals inc. business segments

About Stock Overview & Key Data

Universe Pharmaceuticals Inc. (UPC) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Mar 23, 2021. As of the latest trading session, UPC stock price is $3.62, with a market capitalization of $2.0M. The stock has returned — over the past 12 months and — year-to-date.

Frequently Asked Questions

As of the latest trading session, Universe Pharmaceuticals Inc. (UPC) stock price is $3.62. The stock is traded on NASDAQ under the ticker symbol UPC. The 52-week range is $2.00 – $11.00.

UPC stock priceUPC quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice